Biobank: Biobank for individuals with prostate cancer - Biobank for prostate cancer controls (Sweden): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 40: | Line 40: | ||
<span style="display:none">dataAvailability::not publicly available</span> | <span style="display:none">dataAvailability::not publicly available</span> | ||
<span style="display:none">hasDataAccessInstructions::[https://snd.gu.se/sv/hitta-data/forskningsdatakatalogen/tillganglighetsnivaer-hos-snd click here to learn more</span> | <span style="display:none">hasDataAccessInstructions::[https://snd.gu.se/sv/hitta-data/forskningsdatakatalogen/tillganglighetsnivaer-hos-snd click here to learn more</span> | ||
<span style="display:none">isDatabase</span> | |||
Revision as of 16:47, 3 December 2025
Go back to Sweden page
Type of database: survey, biobank.
Primary purpose: Store the sample collection and data information to study risk factors for prostate cancer.
Sponsor, manager or home institution: Lund University.
Type of information: cross-sectional. The participants had to submit a blood sample and answer questions regarding medication use, height, weight, alcohol consumption and smoking habit. Click here to learn more.
Source of information: Prostate cancer patients treated in an oncology clinic in southern Sweden were invited to participate in the study.
Data level: patient level.
Number of records: 1000. Click here to learn more.
Date range: 2007 onwards.
Cancer areas of interest: C60-C63: Male genitalia cancer. Click here to learn more.
Data access: not publicly available. Dataset information and contact to request data: Click here to learn access. Instructions to request data for restricted content: click here to learn more.
Contact information: Click here to learn more.